{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:20:40Z","timestamp":1781212840620,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LQ20H270015"],"award-info":[{"award-number":["LQ20H270015"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["GD21H270008"],"award-info":[{"award-number":["GD21H270008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02100-2","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T07:03:14Z","timestamp":1729494194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Grilled nux vomica alleviates myasthenia gravis by inhibiting the JAK2\/STAT3 signaling pathway: a study in a mice model"],"prefix":"10.1186","volume":"29","author":[{"given":"Chao","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"2100_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.medcli.2023.04.006","volume":"161","author":"DA Garc\u00eda Est\u00e9vez","year":"2023","unstructured":"Garc\u00eda Est\u00e9vez DA, Pardo FJ. Myasthenia gravis. Update on diagnosis and therapy. Med Clin. 2023;161:119\u201327.","journal-title":"Med Clin."},{"key":"2100_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","volume":"31","author":"R Mantegazza","year":"2018","unstructured":"Mantegazza R, Bernasconi P, Cavalcante P. Myasthenia gravis: from autoantibodies to therapy. Curr Opin Neurol. 2018;31:517\u201325.","journal-title":"Curr Opin Neurol"},{"key":"2100_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115872","volume":"218","author":"X Chen","year":"2023","unstructured":"Chen X, Qiu J, Gao Z, Liu B, Zhang C, Yu W, et al. Myasthenia gravis: molecular mechanisms and promising therapeutic strategies. Biochem Pharmacol. 2023;218: 115872.","journal-title":"Biochem Pharmacol"},{"key":"2100_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neurol.2020.09.015","volume":"177","author":"P Roche","year":"2021","unstructured":"Roche P, Bouh F. Myasthenia gravis and pregnancy. Revue Neurologique. 2021;177:215\u20139.","journal-title":"Revue Neurologique"},{"key":"2100_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","author":"L Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10112235.","journal-title":"J Clin Med"},{"key":"2100_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060556","author":"E Dziadkowiak","year":"2024","unstructured":"Dziadkowiak E, Baczy\u0144ska D, Waliszewska-Pros\u00f3\u0142 M. MuSK myasthenia gravis-potential pathomechanisms and treatment directed against specific targets. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13060556.","journal-title":"Cells"},{"key":"2100_CR7","doi-asserted-by":"publisher","first-page":"1212757","DOI":"10.3389\/fimmu.2023.1212757","volume":"14","author":"AG Vakrakou","year":"2023","unstructured":"Vakrakou AG, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S, et al. Immunotherapies in MuSK-positive myasthenia gravis; an IgG4 antibody-mediated disease. Front Immunol. 2023;14:1212757.","journal-title":"Front Immunol"},{"key":"2100_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","volume":"36","author":"C Farmakidis","year":"2018","unstructured":"Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ. Treatment of myasthenia gravis. Neurol Clin. 2018;36:311\u201337.","journal-title":"Neurol Clin"},{"key":"2100_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102712","volume":"20","author":"AM Lascano","year":"2021","unstructured":"Lascano AM, Lalive PH. Update in immunosuppressive therapy of myasthenia gravis. Autoimmun Rev. 2021;20: 102712.","journal-title":"Autoimmun Rev"},{"key":"2100_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0000000000000647","volume":"31","author":"R Mantegazza","year":"2019","unstructured":"Mantegazza R, Cavalcante P. Diagnosis and treatment of myasthenia gravis. Curr Opin Rheumatol. 2019;31:623\u201333.","journal-title":"Curr Opin Rheumatol"},{"key":"2100_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.13518","volume":"1412","author":"A Evoli","year":"2018","unstructured":"Evoli A, Alboini PE, Damato V, Iorio R, Provenzano C, Bartoccioni E, et al. Myasthenia gravis with antibodies to MuSK: an update. Ann N Y Acad Sci. 2018;1412:82\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"2100_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/biof.1812","volume":"48","author":"S Xiaoyue","year":"2022","unstructured":"Xiaoyue S, Yanbin L. Myasthenia gravis: The pharmacological basis of traditional Chinese medicine for its clinical application. BioFactors. 2022;48:228\u201338.","journal-title":"BioFactors"},{"key":"2100_CR13","first-page":"1070","volume":"14","author":"EJ Huang","year":"2023","unstructured":"Huang EJ, Wu MH, Wang TJ, Huang TJ, Li YR, Lee CY. Myasthenia gravis: novel findings and perspectives on traditional to regenerative therapeutic interventions. Aging Dis. 2023;14:1070\u201392.","journal-title":"Aging Dis"},{"key":"2100_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1142\/S0192415X18500015","volume":"46","author":"R Guo","year":"2018","unstructured":"Guo R, Wang T, Zhou G, Xu M, Yu X, Zhang X, et al. Botany, phytochemistry, pharmacology and toxicity of Strychnos nux-vomica L.: a review. Am J Chinese Med. 2018;46:1\u201323.","journal-title":"Am J Chinese Med"},{"key":"2100_CR15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.919150","volume":"26","author":"XH Jiang","year":"2020","unstructured":"Jiang XH, Chen Y, Ding YY, Qiu H, Zhou DY, Qiu CL. Effect of grilled nux vomica on differential RNA expression profile of gastrocnemius muscle and toll-like receptor 4 (TLR-4)\/nuclear factor kappa B (NF-kappaB) signaling in experimental autoimmune myasthenia gravis rats. Med Sci Monit. 2020;26: e919150.","journal-title":"Med Sci Monit"},{"key":"2100_CR16","first-page":"2994","volume":"30","author":"Y Zou","year":"2015","unstructured":"Zou Y, Qiu T, Yang F. Research on the immune regulation mechanism of grilled nux vomica in experimental autoimmune myasthenia gravis rats. Zhonghua Zhongyiyao Zazhi. 2015;30:2994\u20138.","journal-title":"Zhonghua Zhongyiyao Zazhi"},{"key":"2100_CR17","first-page":"9043822","volume":"2022","author":"C Qiu","year":"2022","unstructured":"Qiu C, Chen Q, Hou Q, Qi G. Systems pharmacology and molecular docking reveals the mechanisms of nux vomica for the prevention of myasthenia gravis. Evid Based Compl Alternat Med. 2022;2022:9043822.","journal-title":"Evid Based Compl Alternat Med"},{"key":"2100_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4161\/jkst.20446","volume":"1","author":"HD Hofmann","year":"2012","unstructured":"Hofmann HD, Kirsch M. JAK2-STAT3 signaling: a novel function and a novel mechanism. Jak-stat. 2012;1:191\u20133.","journal-title":"Jak-stat"},{"key":"2100_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12020-019-01880-6","volume":"64","author":"CD Li","year":"2019","unstructured":"Li CD, Zhao JY, Chen JL, Lu JH, Zhang MB, Huang Q, et al. Mechanism of the JAK2\/STAT3-CAV-1-NR2B signaling pathway in painful diabetic neuropathy. Endocrine. 2019;64:55\u201366.","journal-title":"Endocrine"},{"key":"2100_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109693","volume":"115","author":"Y Lu","year":"2023","unstructured":"Lu Y, Ma Q, Yu L, Huang H, Liu X, Chen P, et al. JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17\/Treg cells via regulating the JAK2\/STAT3-AKT\/mTOR signaling pathway. Int Immunopharmacol. 2023;115: 109693.","journal-title":"Int Immunopharmacol"},{"key":"2100_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12026-020-09164-2","volume":"69","author":"Y Xu","year":"2021","unstructured":"Xu Y, Huang X, Li F, Liu T, Yang T, Chen F, et al. IL-21 enhances STAT3\/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis. Immunol Res. 2021;69:59\u201370.","journal-title":"Immunol Res"},{"key":"2100_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neulet.2017.05.040","volume":"656","author":"CC Wang","year":"2017","unstructured":"Wang CC, Zhang M, Li H, Li XL, Yue LT, Zhang P, et al. Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibition of STAT3. Neurosci Lett. 2017;656:169\u201376.","journal-title":"Neurosci Lett"},{"key":"2100_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2015.02.009","volume":"270","author":"E Tuzun","year":"2015","unstructured":"Tuzun E, Berrih-Aknin S, Brenner T, Kusner LL, Le Panse R, Yang H, et al. Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization. Exp Neurol. 2015;270:11\u20137.","journal-title":"Exp Neurol"},{"key":"2100_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.expneurol.2014.12.013","volume":"270","author":"WD Phillips","year":"2015","unstructured":"Phillips WD, Christadoss P, Losen M, Punga AR, Shigemoto K, Verschuuren J, et al. Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis. Exp Neurol. 2015;270:29\u201340.","journal-title":"Exp Neurol"},{"key":"2100_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","volume":"263","author":"S Binks","year":"2016","unstructured":"Binks S, Vincent A, Palace J. Myasthenia gravis: a clinical-immunological update. J Neurol. 2016;263:826\u201334.","journal-title":"J Neurol"},{"key":"2100_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14:1023\u201336.","journal-title":"Lancet Neurol"},{"key":"2100_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-016-2514-1","author":"K Patel","year":"2017","unstructured":"Patel K, Laloo D, Singh GK, Gadewar M, Patel DK. A review on medicinal uses, analytical techniques and pharmacological activities of Strychnos nux-vomica Linn.: a concise report. Chinese J Int Med. 2017. https:\/\/doi.org\/10.1007\/s11655-016-2514-1.","journal-title":"Chinese J Int Med"},{"key":"2100_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11655-020-3196-2","volume":"27","author":"TY Dai","year":"2021","unstructured":"Dai TY, Chen CC, Hong LL, Ge HP, Pei J, Lyu WQ, et al. Effect evaluation of Strychnos nux-vomica L. with integrative methods for bortezomib-induced peripheral neuropathy in multiple myeloma patients: a self-controlled clinical trial. Chinese J Int Med. 2021;27:131\u20136.","journal-title":"Chinese J Int Med"},{"key":"2100_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0378-8741(03)00224-1","volume":"88","author":"W Yin","year":"2003","unstructured":"Yin W, Wang TS, Yin FZ, Cai BC. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. J Ethnopharmacol. 2003;88:205\u201314.","journal-title":"J Ethnopharmacol"},{"key":"2100_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jep.2018.12.045","volume":"233","author":"G Yu","year":"2019","unstructured":"Yu G, Qian L, Yu J, Tang M, Wang C, Zhou Y, et al. Brucine alleviates neuropathic pain in mice via reducing the current of the sodium channel. J Ethnopharmacol. 2019;233:56\u201363.","journal-title":"J Ethnopharmacol"},{"key":"2100_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12906-020-02950-3","volume":"20","author":"A Razzaq","year":"2020","unstructured":"Razzaq A, Hussain G, Rasul A, Xu J, Zhang Q, Malik SA, et al. Strychnos nux-vomica L seed preparation promotes functional recovery and attenuates oxidative stress in a mouse model of sciatic nerve crush injury. BMC Complement Med Therapies. 2020;20:181.","journal-title":"BMC Complement Med Therapies."},{"key":"2100_CR32","first-page":"131","volume":"27","author":"G Dong","year":"2005","unstructured":"Dong G, Hou Q, Pei J, Wang Y, Qiu CL. Experimental study on rabbit myasthenia gravis treated with grilled Nux Vomica: Zhejiang college of traditional Chinese medicine. Chinese J Int Med. 2005;27:131\u20136.","journal-title":"Chinese J Int Med"},{"key":"2100_CR33","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","volume":"263","author":"N Melzer","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, et al. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the guidelines of the german neurological society. J Neurol. 2016;263:1473\u201394.","journal-title":"J Neurol"},{"key":"2100_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113509","volume":"267","author":"P Mishra","year":"2021","unstructured":"Mishra P, Mittal AK, Rajput SK, Sinha JK. Cognition and memory impairment attenuation via reduction of oxidative stress in acute and chronic mice models of epilepsy using antiepileptogenic nux vomica. J Ethnopharmacol. 2021;267: 113509.","journal-title":"J Ethnopharmacol"},{"key":"2100_CR35","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.29510","volume":"3","author":"DJ Raible","year":"2014","unstructured":"Raible DJ, Frey LC, Brooks-Kayal AR. Effects of JAK2-STAT3 signaling after cerebral insults. Jak-stat. 2014;3: e29510.","journal-title":"Jak-stat"},{"key":"2100_CR36","first-page":"321","volume":"23","author":"XM Chen","year":"2019","unstructured":"Chen XM, Yu YH, Wang L, Zhao XY, Li JR. Effect of the JAK2\/STAT3 signaling pathway on nerve cell apoptosis in rats with white matter injury. Eur Rev Med Pharmacol Sci. 2019;23:321\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2100_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neuron.2011.11.024","volume":"73","author":"CS Nicolas","year":"2012","unstructured":"Nicolas CS, Peineau S, Amici M, Csaba Z, Fafouri A, Javalet C, et al. The Jak\/STAT pathway is involved in synaptic plasticity. Neuron. 2012;73:374\u201390.","journal-title":"Neuron"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02100-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02100-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02100-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T19:03:42Z","timestamp":1729537422000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02100-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2100"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02100-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the ethical committee of Zhejiang Chinese Medical University and were conducted following the Guide for the Care and Use of Laboratory Animals (IACUC-20201109\u201302).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"507"}}